Growth Metrics

EyePoint Pharmaceuticals (EYPT) Other Accumulated Expenses: 2012-2018

Historic Other Accumulated Expenses for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Jun 2018 value amounting to $38,000.

  • EyePoint Pharmaceuticals' Other Accumulated Expenses rose 259.09% to $79,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $79,000, marking a year-over-year increase of 259.09%. This contributed to the annual value of $38,000 for FY2018, which is 111.11% up from last year.
  • As of FY2018, EyePoint Pharmaceuticals' Other Accumulated Expenses stood at $38,000, which was up 111.11% from $18,000 recorded in FY2017.
  • EyePoint Pharmaceuticals' Other Accumulated Expenses' 5-year high stood at $56,000 during FY2016, with a 5-year trough of $7,000 in FY2014.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Other Accumulated Expenses value was $38,000 (recorded in 2018), while the average stood at $37,333.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Other Accumulated Expenses soared by 600.00% in 2014, and later plummeted by 67.86% in 2017.
  • EyePoint Pharmaceuticals' Other Accumulated Expenses (Yearly) stood at $7,000 in 2014, then spiked by 300.00% to $28,000 in 2015, then soared by 100.00% to $56,000 in 2016, then crashed by 67.86% to $18,000 in 2017, then spiked by 111.11% to $38,000 in 2018.